Piramal Pharma Solutions Executive and Leadership Team

Bhargava Chari, the Chief Executive Officer at Piramal Pharma Solutions, directs the overarching corporate strategy and global business operations. Overseeing all functional areas, Chari ensures alignment with the company's mission to provide end-to-end development and manufacturing solutions across the drug life cycle. This leadership role involves driving market expansion and fostering innovation within the Contract Development and Manufacturing Organization (CDMO) sector. By optimizing resource allocation and strategic partnerships, Bhargava Chari directly impacts the company's growth trajectory and its ability to serve innovator and generic companies worldwide. Ultimately, Chari secures Piramal Pharma Solutions' position as a partner of choice through a focus on technological advancement and client-centric service delivery.

Sourabh Lodhi, the Co-Chief Executive Officer at Piramal Pharma Solutions, shares responsibility for the company's strategic direction and operational execution. Lodhi focuses on enhancing the integrated network of facilities across North America, Europe, and Asia, ensuring seamless service delivery for clients. This leadership position involves driving operational efficiencies and expanding the company's service portfolio, which includes drug discovery, process development, and commercial supply of APIs and finished dosage forms. By championing cross-functional collaboration, Sourabh Lodhi ensures that Piramal Pharma Solutions maintains its reputation for reliability and excellence. The Co-Chief Executive Officer's efforts are critical in navigating the complexities of the pharmaceutical industry and delivering value to a global customer base.

Herve Berdou, the Chief Operating Officer at Piramal Pharma Solutions, manages the day-to-day operational execution across the company's global network of facilities. Berdou ensures the efficient and effective delivery of end-to-end development and manufacturing solutions, from clinical trial supplies to commercial API production. This critical role involves optimizing supply chain logistics, enhancing manufacturing processes, and maintaining the highest standards of quality and compliance across North America, Europe, and Asia. By driving operational excellence, Herve Berdou supports the company's ability to offer a comprehensive range of services, including specialized areas like biologics, gene therapies, and potent solid oral drug products. The Chief Operating Officer's leadership is fundamental to Piramal Pharma Solutions' commitment to being a trusted service provider worldwide.

Rubina Malik, the Chief Technology Officer at Piramal Pharma Solutions, architects the company's technological vision and innovation roadmap. Malik oversees the integration and advancement of cutting-edge technologies across all development and manufacturing processes, ensuring Piramal Pharma Solutions remains at the forefront of the CDMO industry. This role is pivotal in driving the adoption of specialized services, including the development of highly potent APIs, antibody-drug conjugations, and sterile fill/finish capabilities. By fostering a culture of continuous improvement and digital transformation, Rubina Malik enhances the company's capacity to deliver complex pharmaceutical solutions. The Chief Technology Officer's strategic initiatives are essential for maintaining a competitive edge and supporting the diverse needs of global clients.